CASR and cardiac hypertrophy: In the cardiac hypertrophy and heart failure model of Wistar rats, the subcutaneous injection of isoproterenol activated the CaSR, increased Ca2+ concentration in the mitochondria, decreased the mitochondrial membrane potential, and induced the release of cytochrome c from the mitochondria during ER stress and apoptosis [54].